Developer docs
API playgroundTry for free, no card

Search company profiles

Valkai.ai

Full company profile

uuid00q42qc

Namestring
Valkai.ai
Legal namestring
Valkai
Websiteurl
valkai.ai
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Valkai.ai is a privately held enterprise software company that markets itself as an "Agent Systems for Life Sciences" platform. Its product is a coordinated AI agent layer that connects a customer's internal enterprise data, external industry data sources, and AI agents into a single orchestrated layer, deployed into the workflows of large pharmaceutical, biotechnology, and medical device companies. The company states that more than 20,000 users at top pharmaceutical firms are already running on the platform and that its agents compress work that historically took months into weeks across the full life sciences pipeline, from research through development. The product is positioned around three AI capability types — autonomous agents, knowledge retrieval, and process automation — operating on text and structured data inputs in regulated environments requiring enterprise-grade security and compliance.

The company is headquartered in West New York, United States, and describes its operating scope as worldwide, with no disclosed geographic restrictions. Its go-to-market is a high-touch enterprise sales motion: the website funnels prospects to "Let's Talk" CTAs and a Google Calendar scheduling link, and there is no public pricing, self-serve tier, or freemium path, indicating quote-based contracts with large life sciences buyers. The founding team is described as combining decades of experience across life sciences, regulation, and AI innovation, and the company is actively hiring across every function. No founding date, incorporation jurisdiction, headcount, funding history, or named customers are disclosed in the available material, leaving ownership structure and corporate history as data gaps. The product is delivered through a hosted login portal at app.valkai.com, and marketing presence is limited to organic social on X (Twitter) and LinkedIn plus a small set of SEO-oriented website pages.

Short descriptiontext

Valkai.ai is a privately held enterprise software company that deploys AI agent systems connecting internal data, industry sources, and AI agents into a coordinated layer for large pharmaceutical, biotechnology, and medical device companies. Over 20,000 users across top pharma firms reportedly run on the platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
agentic AI platform, life sciences AI, pharma workflow automation, enterprise AI agents, regulatory data coordination
Product category
Life Sciences AI Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise agent system deployment
TypeSubscription Recurring
Description

Valkai deploys agent systems to large pharma, biotech, and medical device customers via a high-touch enterprise sales motion (Let's Talk / Schedule a call). No explicit pricing model is disclosed, but the enterprise SaaS posture, deployed user base of 20,000+ across top pharma, and "Login" portal imply a recurring subscription or platform licensing arrangement with multi-year enterprise contracts.

valkai.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Quote-based enterprise offering (no public tiers)
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is not publicly disclosed; prospects must book a call via the "Let's Talk" / Schedule a call CTA.

valkai.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Valkai deploys AI agent systems branded as "Agent Systems for Life Sciences" that connect a customer's internal enterprise data, external industry sources, and AI agents into a single coordinated layer. The platform is targeted at large pharma, biotech, and medical device companies to remove coordination blockers and compress pipeline work that historically took months into weeks, with enterprise-grade security and compliance for regulated environments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduces work that previously took months to weeks across the full life sciences pipeline
+1 more record
Product overview1 text field

Valkai.ai offers a single unified product, "Valkai Agent Systems" (tagline: "Agent Systems for Life Sciences"), positioned as the company's core platform rather than a suite of separate modules. The platform deploys coordinated AI agent systems that connect a customer's internal data, industry sources, and AI agents into one orchestrated layer, enabling life sciences teams at pharma, biotech, and medical device companies to remove blockers, fill gaps, and compress work that previously took months into weeks. Over 20,000 users across top pharma companies are stated to be running on the Valkai platform, which is delivered with enterprise-grade security, data privacy, and compliance controls.

Product and service1 record
1Valkai Agent Systems
CategoryAI Agent Platform
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Enterprise data and AI platform (Foundry/AIP) used by large pharma for pipeline, manufacturing, and commercial operations; comparable as a broad incumbent offering overlapping agentic workflow capabilities in life sciences.

TypeDirect peer
Description

Data and AI platform purpose-built for life sciences R&D that connects internal lab data with industry sources; directly comparable because it underpins the same data-layer and workflow automation use cases Valkai targets.

TypeDirect peer
Description

Cloud R&D platform for life sciences used by large pharma and biotech; directly comparable because it sits inside the same buyer workflows that Valkai's agent layer targets and is shown as a logo on Valkai's own homepage.

TypeBroad incumbent
Description

Established AI-driven drug discovery company operating broadly across the pharma pipeline; comparable as a more mature vertical AI-for-life-sciences player targeting similar enterprise buyers.

TypeBroad incumbent
Description

Publicly listed AI drug discovery company combining high-throughput biology with ML; comparable as an established vertical life sciences AI platform competing for similar R&D and pipeline budgets.

TypeDirect peer
Description

Enterprise AI search and agent platform; directly comparable because it sells agentic AI into regulated enterprises and is explicitly referenced on Valkai's homepage as part of its ecosystem positioning.

TypeDirect peer
Description

AI-native pharma company building agentic and AI tooling for drug development; directly comparable because it applies AI agents across the life sciences pipeline and is listed as a Valkai ecosystem logo.

TypeBroad incumbent
Description

Enterprise AI application platform with life sciences deployments; comparable as a broad incumbent offering vertical AI applications that overlap with Valkai's enterprise workflow positioning.

TypeEmerging player
Description

Early-stage AI drug discovery company building foundation models and agentic systems for life sciences; comparable as a more specialized emerging player in the AI-for-life-sciences category Valkai targets.

TypeEmerging player
Description

AI platform for healthcare and life sciences R&D that connects multimodal biomedical data with AI models; comparable as an emerging vertical player addressing similar enterprise pharma data and AI workflow needs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Valkai.ai

Life Sciences AI Softwarevalkai.ai

Valkai.ai is a privately held enterprise software company that deploys AI agent systems connecting internal data, industry sources, and AI agents into a coordinated layer for large pharmaceutical, biotechnology, and medical device companies. Over 20,000 users across top pharma firms reportedly run on the platform.

What Valkai.ai does

Valkai.ai is a privately held enterprise software company that markets itself as an "Agent Systems for Life Sciences" platform. Its product is a coordinated AI agent layer that connects a customer's internal enterprise data, external industry data sources, and AI agents into a single orchestrated layer, deployed into the workflows of large pharmaceutical, biotechnology, and medical device companies. The company states that more than 20,000 users at top pharmaceutical firms are already running on the platform and that its agents compress work that historically took months into weeks across the full life sciences pipeline, from research through development. The product is positioned around three AI capability types — autonomous agents, knowledge retrieval, and process automation — operating on text and structured data inputs in regulated environments requiring enterprise-grade security and compliance.

The company is headquartered in West New York, United States, and describes its operating scope as worldwide, with no disclosed geographic restrictions. Its go-to-market is a high-touch enterprise sales motion: the website funnels prospects to "Let's Talk" CTAs and a Google Calendar scheduling link, and there is no public pricing, self-serve tier, or freemium path, indicating quote-based contracts with large life sciences buyers. The founding team is described as combining decades of experience across life sciences, regulation, and AI innovation, and the company is actively hiring across every function. No founding date, incorporation jurisdiction, headcount, funding history, or named customers are disclosed in the available material, leaving ownership structure and corporate history as data gaps. The product is delivered through a hosted login portal at app.valkai.com, and marketing presence is limited to organic social on X (Twitter) and LinkedIn plus a small set of SEO-oriented website pages.

Valkai.ai firmographics

Firmographics
Name
Valkai.ai
Legal name
Valkai
Website
https://valkai.ai
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
1–10 employees
Short description
Valkai.ai is a privately held enterprise software company that deploys AI agent systems connecting internal data, industry sources, and AI agents into a coordinated layer for large pharmaceutical, biotechnology, and medical device companies. Over 20,000 users across top pharma firms reportedly run on the platform.
Ownership category
akta.pro rank

Where Valkai.ai is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Markets served

Valkai.ai business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Enterprise agent system deployment: Valkai deploys agent systems to large pharma, biotech, and medical device customers via a high-touch enterprise sales motion (Let's Talk / Schedule a call). No explicit pricing model is disclosed, but the enterprise SaaS posture, deployed user base of 20,000+ across top pharma, and "Login" portal imply a recurring subscription or platform licensing arrangement with multi-year enterprise contracts.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based enterprise offering (no public tiers)

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Valkai.ai product offering

Product offering

Core offering

Valkai deploys AI agent systems branded as "Agent Systems for Life Sciences" that connect a customer's internal enterprise data, external industry sources, and AI agents into a single coordinated layer. The platform is targeted at large pharma, biotech, and medical device companies to remove coordination blockers and compress pipeline work that historically took months into weeks, with enterprise-grade security and compliance for regulated environments.

Product overview

Valkai.ai offers a single unified product, "Valkai Agent Systems" (tagline: "Agent Systems for Life Sciences"), positioned as the company's core platform rather than a suite of separate modules. The platform deploys coordinated AI agent systems that connect a customer's internal data, industry sources, and AI agents into one orchestrated layer, enabling life sciences teams at pharma, biotech, and medical device companies to remove blockers, fill gaps, and compress work that previously took months into weeks. Over 20,000 users across top pharma companies are stated to be running on the Valkai platform, which is delivered with enterprise-grade security, data privacy, and compliance controls.

Differentiator

Problem solved

Functional benefit

Products and services

  • Valkai Agent Systems

Quantifiable outcome

  • Reduces work that previously took months to weeks across the full life sciences pipeline
  • +1 more outcomes

Companies that use Valkai.ai

Customer profile

Segments3 records

Ideal customer profiles1 record

Valkai.ai technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Valkai.ai partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Valkai.ai competitors and assessment

Company assessment

Broad incumbents

  • Palantir Technologies: Enterprise data and AI platform (Foundry/AIP) used by large pharma for pipeline, manufacturing, and commercial operations; comparable as a broad incumbent offering overlapping agentic workflow capabilities in life sciences.
  • Insilico Medicine: Established AI-driven drug discovery company operating broadly across the pharma pipeline; comparable as a more mature vertical AI-for-life-sciences player targeting similar enterprise buyers.
  • Recursion: Publicly listed AI drug discovery company combining high-throughput biology with ML; comparable as an established vertical life sciences AI platform competing for similar R&D and pipeline budgets.
  • C3.ai: Enterprise AI application platform with life sciences deployments; comparable as a broad incumbent offering vertical AI applications that overlap with Valkai's enterprise workflow positioning.

Direct peers

  • TetraScience: Data and AI platform purpose-built for life sciences R&D that connects internal lab data with industry sources; directly comparable because it underpins the same data-layer and workflow automation use cases Valkai targets.
  • Benchling: Cloud R&D platform for life sciences used by large pharma and biotech; directly comparable because it sits inside the same buyer workflows that Valkai's agent layer targets and is shown as a logo on Valkai's own homepage.
  • Glean: Enterprise AI search and agent platform; directly comparable because it sells agentic AI into regulated enterprises and is explicitly referenced on Valkai's homepage as part of its ecosystem positioning.
  • Formation Bio: AI-native pharma company building agentic and AI tooling for drug development; directly comparable because it applies AI agents across the life sciences pipeline and is listed as a Valkai ecosystem logo.

Emerging players

  • Iambic (formerly Entos): Early-stage AI drug discovery company building foundation models and agentic systems for life sciences; comparable as a more specialized emerging player in the AI-for-life-sciences category Valkai targets.
  • Owkin: AI platform for healthcare and life sciences R&D that connects multimodal biomedical data with AI models; comparable as an emerging vertical player addressing similar enterprise pharma data and AI workflow needs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Valkai.ai social profiles

Digital presence

Valkai.ai financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Valkai.ai leadership team

Management profile

Number of profiles

Valkai.ai funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Valkai.ai M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valkai.ai

What does Valkai.ai do?

Valkai deploys AI agent systems branded as "Agent Systems for Life Sciences" that connect a customer's internal enterprise data, external industry sources, and AI agents into a single coordinated layer. The platform is targeted at large pharma, biotech, and medical device companies to remove coordination blockers and compress pipeline work that historically took months into weeks, with enterprise-grade security and compliance for regulated environments.

Is Valkai.ai a public or private company?

Valkai.ai is a private company. It is classified as unknown and is currently operating.

When was Valkai.ai founded?

Valkai.ai was founded in 2024. It employs 1 to 10 people.

Where is Valkai.ai based?

Valkai.ai is headquartered in Austin, United States, in the North America region.

How does Valkai.ai make money?

One revenue line is on record: enterprise agent system deployment.

Who are Valkai.ai's main competitors?

Broad incumbents on record are Palantir Technologies, Insilico Medicine, Recursion and C3.ai. Direct peers are TetraScience, Benchling, Glean and Formation Bio. Emerging players are Iambic (formerly Entos) and Owkin.

Does Valkai.ai have an API?

No public API is recorded for Valkai.ai.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals